Cilastatin (CAS 82009-34-5) Dehydropeptidase Inhibitor Pharmaceutical API

Cilastatin (CAS 82009-34-5) is a highly specific dehydropeptidase inhibitor API, playing a pivotal role in enhancing the efficacy of antibacterial medications. Its unique molecular mechanism targets and inhibits renal dehydropeptidase I, preventing the degradation of beta-lactam antibiotics (such as imipenem) in the kidneys. This high-purity pharmaceutical raw material adheres to stringent quality control standards, ensuring consistent performance and stability.

Primarily designed for pharmaceutical formulation, it is widely used in combination with broad-spectrum antibiotics to extend their half-life and improve bioavailability, enabling more effective treatment of severe bacterial infections. Suitable for developing injectable or oral antibacterial combinations, it addresses the critical need for sustained antibiotic activity in clinical settings. Trust this premium API to optimize antibiotic formulations and enhance therapeutic outcomes for patients.